Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
04 08 2023
Historique:
received: 05 07 2022
accepted: 18 07 2023
medline: 7 8 2023
pubmed: 5 8 2023
entrez: 4 8 2023
Statut: epublish

Résumé

Electromechanical characterization during atrial fibrillation (AF) remains a significant gap in the understanding of AF-related atrial myopathy. This study reports mechanistic insights into the electromechanical remodeling process associated with AF progression and further demonstrates its prognostic value in the clinic. In pigs, sequential electromechanical assessment during AF progression shows a progressive decrease in mechanical activity and early dissociation from its electrical counterpart. Atrial tissue samples from animals with AF reveal an abnormal increase in cardiomyocytes death and alterations in calcium handling proteins. High-throughput quantitative proteomics and immunoblotting analyses at different stages of AF progression identify downregulation of contractile proteins and progressive increase in atrial fibrosis. Moreover, advanced optical mapping techniques, applied to whole heart preparations during AF, demonstrate that AF-related remodeling decreases the frequency threshold for dissociation between transmembrane voltage signals and intracellular calcium transients compared to healthy controls. Single cell simulations of human atrial cardiomyocytes also confirm the experimental results. In patients, non-invasive assessment of the atrial electromechanical relationship further demonstrate that atrial electromechanical dissociation is an early prognostic indicator for acute and long-term rhythm control.

Identifiants

pubmed: 37542075
doi: 10.1038/s41467-023-40196-y
pii: 10.1038/s41467-023-40196-y
pmc: PMC10403561
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4613

Informations de copyright

© 2023. The Author(s).

Références

Philos Trans A Math Phys Eng Sci. 2016 Apr 13;374(2065):20150196
pubmed: 26953177
J Proteome Res. 2015 Feb 6;14(2):700-10
pubmed: 25494653
Eur Heart J. 2020 Mar 7;41(10):1123-1131
pubmed: 31713590
J Am Coll Cardiol. 1994 Jun;23(7):1535-40
pubmed: 8195510
Cardiovasc Res. 2021 Jun 16;117(7):1790-1801
pubmed: 32520995
Bioinformatics. 2019 May 1;35(9):1594-1596
pubmed: 30252043
Circ Arrhythm Electrophysiol. 2020 Apr;13(4):e008128
pubmed: 32191539
J Cardiovasc Electrophysiol. 2009 Dec;20(12):1374-81
pubmed: 19817923
Circ Res. 2014 Apr 25;114(9):1410-21
pubmed: 24568740
Cardiovasc Res. 2021 Jun 16;117(7):1-21
pubmed: 33913486
J Interv Card Electrophysiol. 2020 Jan;57(1):87-95
pubmed: 31889225
Europace. 2014 Nov;16(11):1569-74
pubmed: 24692517
J Proteome Res. 2014 Mar 7;13(3):1234-47
pubmed: 24512137
Europace. 2018 Jul 1;20(7):e96-e104
pubmed: 29016756
Heart Rhythm. 2014 Mar;11(3):478-84
pubmed: 24321238
Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12
pubmed: 17569110
J Mol Cell Cardiol. 2016 Dec;101:26-34
pubmed: 27773652
Circ Res. 2009 Oct 23;105(9):876-85
pubmed: 19762679
J Cardiovasc Med (Hagerstown). 2019 Nov;20(11):745-751
pubmed: 31483328
Circulation. 2005 Jul 19;112(3):387-95
pubmed: 16006491
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Circ Res. 2019 Aug 30;125(6):609-627
pubmed: 31366278
Heart Rhythm. 2014 Sep;11(9):1514-21
pubmed: 24768608
Europace. 2020 May 1;22(5):704-715
pubmed: 31840163
Int J Cardiol. 2005 Jul 20;102(3):447-54
pubmed: 16004890
Echo Res Pract. 2020 Feb 27;7(1):G19-G41
pubmed: 32105053
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Am J Cardiol. 1998 Dec 15;82(12):1545-7, A8
pubmed: 9874066
Cardiovasc Res. 2004 Mar 1;61(4):764-70
pubmed: 14985073
Circulation. 2014 Apr 8;129(14):1472-82
pubmed: 24463369
JCI Insight. 2020 Oct 2;5(19):
pubmed: 32910807
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487

Auteurs

Daniel Enríquez-Vázquez (D)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Servicio de Cardiología, Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Jorge G Quintanilla (JG)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Alba García-Escolano (A)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
ETSI Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.

Marinela Couselo-Seijas (M)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Ana Simón-Chica (A)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Peter Lee (P)

Essel Research and Development Inc., Toronto, ON, Canada.

José Manuel Alfonso-Almazán (JM)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Patricia Mahía (P)

Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Andrés Redondo-Rodríguez (A)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Javier Modrego (J)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Laboratorio de Microbiota y Biología Vascular, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Adriana Ortega-Hernández (A)

Laboratorio de Microbiota y Biología Vascular, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Pedro Marcos-Alberca (P)

Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Ricardo Magni (R)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Enrique Calvo (E)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Rubén Gómez-Gordo (R)

Laboratorio de Microbiota y Biología Vascular, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Ping Yan (P)

Richard D. Berlin Center for Cell Analysis and Modeling, University of Connecticut School of Medicine, Farmington, CT, USA.

Giulio La Rosa (G)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

José Bustamante-Madrión (J)

Emergency Department, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Carlos Nicolás Pérez-García (CN)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

F Javier Martín-Sánchez (FJ)

Emergency Department, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

David Calvo (D)

Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.

Jesús M de la Hera (JM)

Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.

María Jesús García-Torrent (MJ)

Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Álvaro García-Osuna (Á)

Department of Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques, IIB Sant Pau, Barcelona, Spain.

Jordi Ordonez-Llanos (J)

Department of Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Universidad Autónoma, Barcelona, Spain.
Foundation for Clinical Biochemistry & Molecular Pathology, Madrid, Spain.

Jesús Vázquez (J)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Julián Pérez-Villacastín (J)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Fundación Interhospitalaria para la Investigación Cardiovascular (FIC), Madrid, Spain.

Nicasio Pérez-Castellano (N)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
Fundación Interhospitalaria para la Investigación Cardiovascular (FIC), Madrid, Spain.

Leslie M Loew (LM)

Richard D. Berlin Center for Cell Analysis and Modeling, University of Connecticut School of Medicine, Farmington, CT, USA.

Javier Sánchez-González (J)

Philips Healthcare Iberia, Madrid, Spain.

Dulcenombre Gómez-Garre (D)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Laboratorio de Microbiota y Biología Vascular, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

David Filgueiras-Rama (D)

Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. david.filgueiras@cnic.es.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. david.filgueiras@cnic.es.
Cardiovascular Institute, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain. david.filgueiras@cnic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH